JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 22, 2006; DOI: 10.1124/jpet.106.109868


0022-3565/06/3192-657-662$20.00
JPET 319:657-662, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.106.109868v1
jpet.106.109868v2
319/2/657    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heckl, S.
Right arrow Articles by Vogel, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heckl, S.
Right arrow Articles by Vogel, U.

METABOLISM, TRANSPORT, AND PHARMACOGENOMICS

Nuclear Trafficking of a Gadolinium Conjugate in Nude Mice Xenografted with Human LN-229 GliomaFormula

Stefan Heckl, and Ulrich Vogel

Departments of Neuroradiololgy (S.H.) and Pathology (U.V.), University of Tübingen, Tübingen, Germany

We synthesized a novel fluorescein isothiocyanate-labeled gadolinium-diethylenetriamine pentaacetic acid (DTPA) conjugate in which the commonly used gadolinium-DTPA complex is flanked by the nuclear localization sequences of the simian virus-40 T antigen and the acute lymphatic leukemia-1 (ALL-1) protein. The distribution of the conjugate after i.p. or i.v. injection in nude mice bearing human LN-229 glioma xenografts was confirmed by magnetic resonance imaging, with an increase in signal intensity in all the organs and tumors except for healthy brain parenchyma with an intact blood-brain barrier. Nuclear uptake and efflux of the conjugate was demonstrated by confocal laser scanning microscopy. Such gadolinium conjugates may therefore be of value in the development of novel diagnostic and therapeutic agents.


Received for publication June 23, 2006
Accepted August 18, 2006.

Address correspondence to: Dr. Stefan Heckl, Department of Neuroradiology, University of Tübingen, Medical School, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany. E-mail: stefan.heckl{at}med.uni-tuebingen.de







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.